Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient
- PMID: 10721883
- DOI: 10.1055/s-2000-7963
Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient
Abstract
A 30-year-old male patient with paranoid schizophrenia was on clozapine therapy for more than five years. Discontinuation of clozapine and an attempt to change his medication to sertindole has led to serious psychotic and somatic symptoms. After readministration of clozapine the psychotic symptoms rapidly disappeared. The patient was monitored by BPRS and PANSS positive and negative scale. Also clinical and labor parameters of the patient were monitored. The change of his medication from clozapine to sertindole was unsuccessful. This case report suggests that although atypical antipsychotics may be generally different from the classical neuroleptic drugs, there are also significant differences among the atypical antipsychotic drugs in their effects on the receptors of the central nervous system. Therefore the change of clozapine to another atypical antipsychotic medication in the clinical practice should be cross-tapered and the symptoms of withdrawal closely monitored.
Similar articles
-
[Relationship between clozapine plasma levels and withdrawal symptoms].Actas Esp Psiquiatr. 2002 Nov-Dec;30(6):397-9. Actas Esp Psiquiatr. 2002. PMID: 12487951 Spanish.
-
Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report.Biol Psychiatry. 1996 May 1;39(9):814-5. doi: 10.1016/0006-3223(95)00550-1. Biol Psychiatry. 1996. PMID: 8731523 No abstract available.
-
Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.J Clin Psychopharmacol. 2012 Apr;32(2):173-8. doi: 10.1097/JCP.0b013e318248dfb8. J Clin Psychopharmacol. 2012. PMID: 22367659 Clinical Trial.
-
[Clozapine and treatment of negative symptoms].Encephale. 1997 Sep;23 Spec No 4:7-11. Encephale. 1997. PMID: 9417403 Review. French.
-
Sertindole: a review of clinical efficacy.Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S59-63; discussion S63-4. Int Clin Psychopharmacol. 1998. PMID: 9690972 Review.
Cited by
-
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.CNS Drugs. 2013 Jul;27(7):545-72. doi: 10.1007/s40263-013-0079-5. CNS Drugs. 2013. PMID: 23821039 Review.
-
Clozapine discontinuation withdrawal symptoms in schizophrenia.Ther Adv Psychopharmacol. 2021 Sep 18;11:20451253211032053. doi: 10.1177/20451253211032053. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34552710 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources